ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-24 |

Results: 24

BODY-FLUID MARKERS TO MONITOR MULTIPLE-SCLEROSIS - THE ASSAYS AND THECHALLENGES

Authors: LAMAN JD THOMPSON EJ KAPPOS L

Citation: Jd. Laman et al., BODY-FLUID MARKERS TO MONITOR MULTIPLE-SCLEROSIS - THE ASSAYS AND THECHALLENGES, Multiple sclerosis, 4(3), 1998, pp. 266-269

TREATMENT - RELAPSING PHASE OF MULTIPLE-SCLEROSIS

Authors: KAPPOS L LEPPERT D RADU EV

Citation: L. Kappos et al., TREATMENT - RELAPSING PHASE OF MULTIPLE-SCLEROSIS, European journal of neurology, 5, 1998, pp. 23-24

BALANCING THE TH1 TH2 CONCEPT IN MULTIPLE-SCLEROSIS/

Authors: LAMAN JD THOMPSON EJ KAPPOS L

Citation: Jd. Laman et al., BALANCING THE TH1 TH2 CONCEPT IN MULTIPLE-SCLEROSIS/, Immunology today, 19(11), 1998, pp. 489-490

PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS

Authors: KAPPOS L POLMAN C POZZILLI C THOMPSON A DAHLKE F KNIGHT R HERN J COLEMAN R GERRIE L COOPER G MOORE J BORINGA J VANOOSTEN B RONNER H SCHRIJVER H TRUYEN L MONTALBAN J RIO J TINTORE M JACAS C MARZO E LECHNERSCOTT J HUBER S LIENERT C BRUNNSCHWEILER H HAWKINS S DROOGAN A MCDONNELL G DUDDY M MCKINSTRY S ALTENKIRCH H BAUM K EINHAUPL K MARX P POEWE W WALTER G AKMAN H BROCKMEIER B SCHERER P ZSCHENDERLEIN R SCHMIERER K GELDERBLOM H HARTMANN A STAPF C LUSCHOW A MACKERT B SCHUMACHER H MASUHR F HEMPEL T ZIMMERMANN R MUNCH M FRANCIS D HEAFIELD M ALMEMAR A WINER J CHONG M BROCHET B GAYOU A AURIACOMBE S DOUSSET V WILES C THOMAS F PICKERSGILL T HINDS N DAWSON K HUGHES T HUTCHINSON M MURPHY R REDMOND J WEBB S STOLL G JANDER S HAGEMANN G KOLLER H HANEMANN C KOLMEL H REICHEL D PETEREIT K THIEME A KHATAMI A NEUMANN M AMADUCCI L MASSACESI L SIRACUSA G AMATO M BARTOLOZZI L REPICE A MINDERHOUD J DEKEYSER J ZORGDRAGER A ZWANIKKEN C POSER S POLAK T GUNTHER A BITSCH A BORNER T WEBER F WIKSTROM J FARKKILA M MAJURI H SUMELAHTI M TELAKIVI T FREDRIKSON S MARTIN C MILLER D ORIORDAN J BREX P KAPOOR R WERRING D CONFAVREUX C BRUNET P HANNOUN D BRUDON F MOREAU T BLANC S DHOOGHE M JACOBS K LISSOIR F DEMONTY L COMI G COLOMBO B ROSSI P RODEGHER M SANTUCCIO G MARTINELLI F HOHLFELD R WALTHER E GOEBELS N DANG T LINDERT R VOLTZ R CARTLIDGE N BATES D MORAN G PANDIT L WESTWOOD M HALLER P SOMMER J BITTER J SUSS F MELLIES J MUCHA P LYONCAEN O DEGOS JD ROULLET E LUBETZKI C CREANGE A TOURBAH A PEZ D LECANUET P NICOLT P EDAN G BELLIARD S DEMARCO O CAHAGNE V DEBURGHGRAEVE V BRUNET I FIESCHI C MILLEFIORINI E GASPERINI C BUTTINELLI C FRONTINI M HOWELL S HADJIVASSILIOU M GIBSON A GRAHAM A HARKNESS K LAWDEN M CLANET M WAUBAN E AZAISVUILLEMIN C LAU G LOUIS C PANELIUS M RUUTIAINEN J ERALINNA J SOILUHANNINEN M GOLD R HARTUNG HP JUNG S BAYAS A FLACHENECKER P WEILBACH F ARCHELOS J KOLLEGGER H VASS K ASENBAUM S CHATSAKOS T BECKMANN K GHAZI M WAGNER K MILTENBURGER C MCFARLAND H PETKAU J SABOURAUD O TOYKA K

Citation: L. Kappos et al., PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS, Lancet, 352(9139), 1998, pp. 1491-1497

RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF INTERFERON BETA-1A IN RELAPSING REMITTING MULTIPLE-SCLEROSIS/

Authors: EBERS GC RICE G LESAUX J PATY D OGER J LI DKB BEALL S DEVONSHIRE V HASHIMOTO S HOOGE J KASTRUKOFF L KRIEGER C MEZEI M SELAND P VOROBEYCHI G MORRISON W NELSON J FREEDMAN MS CHRISIE S NELSON R RABINOVITCH H FREEDMAN C HARTUNG HP RIECKMANN P ARCHELOS J JUNG S WEILBACH F FLACHENECKE P SAUER J HOMMES O JONGEN P BROUWER S MCLEOD J POLLARD J NG R SANDBERGWOLLHEIM M KALLEN K NILSSON P EKBERG R LUNDGREN A JADBACK G WIKSTROM J MULTANEN J VALJAKKA M CARTON H LISSOIR F DECLERQ I VIEREN M PEETERS E DUBOIS B DEKEERSMAEKER E VANHERLE A HUGHES RAC SHARRACK B SOUDAIN S PANELIUS M ERALINNA J SOILUHANNINEN M MURTO S MEDAER R BROECKX J VANROOSE E BOGAERS A BLUMHARDT LD EDWARDS S LIU C ORPE V BARNES D SCHWARTZ M STOY N HARRAGHY C BERTELSMANN F UITDEHAAG B NASSERI K CHOFFLON M ROTH S KAPPOS L HUBER S BELLAICHE Y SENN C KING J JUBERT J WHITTEN S NEWSOMDAVIS JM PALACE J LEE M EVANGELOU N PINTO A CAVEY A SINDIC CJM MONTEYNE P VEROUGSTRAETE D VANDOORN PA MOLL W VISSER L WILLEMS M MARTINA I BULJEVAC D LOMAN L BATES D PANDIT D IRVING J RHODES B RIDDEHOUGH A ZHAO GJ WANG X CHENG Y AMMOURY N DUPONT F GALAZKA A HYDE R OLSON M PERNIN MO ABDULAHAD AK HOMMES O NOSEWORTHY J BORDEN E OBRIEN P WOLINSKY J

Citation: Gc. Ebers et al., RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF INTERFERON BETA-1A IN RELAPSING REMITTING MULTIPLE-SCLEROSIS/, Lancet, 352(9139), 1998, pp. 1498-1504

COMPUTER-ASSISTED RETRAINING OF ATTENTIONAL IMPAIRMENTS IN PATIENTS WITH MULTIPLE-SCLEROSIS

Authors: PLOHMANN AM KAPPOS L AMMANN W THORDAI A WITTWER A HUBER S BELLAICHE Y LECHNERSCOTT J

Citation: Am. Plohmann et al., COMPUTER-ASSISTED RETRAINING OF ATTENTIONAL IMPAIRMENTS IN PATIENTS WITH MULTIPLE-SCLEROSIS, Journal of Neurology, Neurosurgery and Psychiatry, 64(4), 1998, pp. 455-462

INTRAVENOUS IMMUNOGLOBULIN (IVIG) TREATMENT FOR PATIENTS WITH PRIMARYOR SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS - OUTLINE OF A DOUBLE-BLIND RANDOMIZED, PLACEBO-CONTROLLED TRIAL

Authors: POEHLAU D FEDERLEIN J POSTERT T SAILER M BETHKE F KAPPOS L HAAS J PRZUNTEK H

Citation: D. Poehlau et al., INTRAVENOUS IMMUNOGLOBULIN (IVIG) TREATMENT FOR PATIENTS WITH PRIMARYOR SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS - OUTLINE OF A DOUBLE-BLIND RANDOMIZED, PLACEBO-CONTROLLED TRIAL, Multiple sclerosis, 3(2), 1997, pp. 149-152

THE MULTIPLE-SCLEROSIS PRISMS STUDY - PREVENTION OF RELAPSES AND DISABILITY BY INTERFERON BETA-1A SUBCUTANEOUSLY IN MULTIPLE-SCLEROSIS

Authors: EBERS GC OGER J PATY D LI D FREEDMAN M HARTUNG HP HOMMES O MCLEOD J SANDBERG M WIKSTROM J CARTON H HUGHES RAC PANCELIUS M MEDAER R BLUMHARDT L BARNES D BERTELSMANN F CHOFFLON M KAPPOS L KING J NEWSOMDAVIS J SINDIC C UITEHAAG B VANDOOM P BATES D DUPONT F GALAZKA A HYDE R PERNIN MO ABDULAHAD A

Citation: Gc. Ebers et al., THE MULTIPLE-SCLEROSIS PRISMS STUDY - PREVENTION OF RELAPSES AND DISABILITY BY INTERFERON BETA-1A SUBCUTANEOUSLY IN MULTIPLE-SCLEROSIS, Annals of neurology, 42(6), 1997, pp. 2-2

STRATEGIES FOR OPTIMIZING MRI TECHNIQUES AIMED AT MONITORING DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS TREATMENT TRIALS

Authors: BARKHOF F FILIPPI M MILLER DH TOFTS P KAPPOS L THOMPSON AJ

Citation: F. Barkhof et al., STRATEGIES FOR OPTIMIZING MRI TECHNIQUES AIMED AT MONITORING DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS TREATMENT TRIALS, Journal of neurology, 244(2), 1997, pp. 76-84

SINGLE-DOSE GADOLINIUM WITH MAGNETIZATION-TRANSFER VERSUS TRIPLE-DOSEGADOLINIUM IN THE MR DETECTION OF MULTIPLE-SCLEROSIS LESIONS

Authors: VANWAESBERGHE JHTM CASTELIJNS JA ROSER W SILVER N YOUSRY T NIJEHOLT GJLA ADER HJ UITDEHAAG BMJ RADUE EW POLMAN CH KAPPOS L MILLER DH BARKHOF F

Citation: Jhtm. Vanwaesberghe et al., SINGLE-DOSE GADOLINIUM WITH MAGNETIZATION-TRANSFER VERSUS TRIPLE-DOSEGADOLINIUM IN THE MR DETECTION OF MULTIPLE-SCLEROSIS LESIONS, American journal of neuroradiology, 18(7), 1997, pp. 1279-1285

INTRACRANIAL ANEURYSMS

Authors: KAPPOS L DOMMASCH D

Citation: L. Kappos et D. Dommasch, INTRACRANIAL ANEURYSMS, The New England journal of medicine, 336(24), 1997, pp. 1758-1758

REDUCED GLUCOSE-METABOLISM IN THE FRONTAL-CORTEX AND BASAL GANGLIA OFMULTIPLE-SCLEROSIS PATIENTS WITH FATIGUE - A F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY STUDY

Authors: ROELCKE U KAPPOS L LECHNERSCOTT J BRUNNSCHWEILER H HUBER S AMMANN W PLOHMANN A DELLAS S MAGUIRE RP MISSIMER J RADU EW STECK A LEENDERS KL

Citation: U. Roelcke et al., REDUCED GLUCOSE-METABOLISM IN THE FRONTAL-CORTEX AND BASAL GANGLIA OFMULTIPLE-SCLEROSIS PATIENTS WITH FATIGUE - A F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY STUDY, Neurology, 48(6), 1997, pp. 1566-1571

THE ROLE OF MATRIX METALLOPROTEINASES IN MULTIPLE-SCLEROSIS

Authors: LEPPERT D HAUSER SL KAPPOS L

Citation: D. Leppert et al., THE ROLE OF MATRIX METALLOPROTEINASES IN MULTIPLE-SCLEROSIS, Journal of neurochemistry, 69, 1997, pp. 219-219

FATAL VASCULAR LEAK SYNDROME WITH EXTENSIVE HEMORRHAGE, PERIPHERAL NEUROPATHY AND REACTIVE ERYTHROPHAGOCYTOSIS - AN UNUSUAL COMPLICATION OFRECOMBINANT IL-3 THERAPY

Authors: HURWITZ N PROBST A ZUFFEREY G TICHELLI A PLESS M KAPPOS L SPECK B GRATWOHL A

Citation: N. Hurwitz et al., FATAL VASCULAR LEAK SYNDROME WITH EXTENSIVE HEMORRHAGE, PERIPHERAL NEUROPATHY AND REACTIVE ERYTHROPHAGOCYTOSIS - AN UNUSUAL COMPLICATION OFRECOMBINANT IL-3 THERAPY, Leukemia & lymphoma, 20(3-4), 1996, pp. 337-340

MULTIPLE-SCLEROSIS - TREATMENT WITH RECOM BINANT INTERFERON BETA-1B

Authors: HUBER S SPYCHER M LECHNERSCOTT J BELLAICHE Y STECK AJ KAPPOS L

Citation: S. Huber et al., MULTIPLE-SCLEROSIS - TREATMENT WITH RECOM BINANT INTERFERON BETA-1B, Schweizerische medizinische Wochenschrift, 126(35), 1996, pp. 1475-1481

15+ --DEOXYSPERGUALINE (DSG) IN THE TREATMENT OF ACTIVE MULTIPLE-SCLEROSIS - FINAL ANALYSIS OF THE EUROPEAN MULTICENTER STUDY/

Authors: KAPPOS L RADU EW DELLAS S HARTARD C HARTUNG HP HALLER P

Citation: L. Kappos et al., 15+ --DEOXYSPERGUALINE (DSG) IN THE TREATMENT OF ACTIVE MULTIPLE-SCLEROSIS - FINAL ANALYSIS OF THE EUROPEAN MULTICENTER STUDY/, Neurology, 46(2), 1996, pp. 55001-55001

HEREDITARY DEFECT OF COBALAMIN METABOLISM (HOMOCYSTINURIA AND METHYLMALONIC ACIDURIA) OF JUVENILE-ONSET

Authors: GOLD R BOGDAHN U KAPPOS L TOYKA KV BAUMGARTNER ER FOWLER B WENDEL U

Citation: R. Gold et al., HEREDITARY DEFECT OF COBALAMIN METABOLISM (HOMOCYSTINURIA AND METHYLMALONIC ACIDURIA) OF JUVENILE-ONSET, Journal of Neurology, Neurosurgery and Psychiatry, 60(1), 1996, pp. 107-108

PROTON MRS OF GADOLINIUM-ENHANCING MS PLAQUES AND METABOLIC CHANGES IN NORMAL-APPEARING WHITE-MATTER

Authors: ROSER W HAGBERG G MADER I BRUNNSCHWEILER H RADUE EW SEELIG J KAPPOS L

Citation: W. Roser et al., PROTON MRS OF GADOLINIUM-ENHANCING MS PLAQUES AND METABOLIC CHANGES IN NORMAL-APPEARING WHITE-MATTER, Magnetic resonance in medicine, 33(6), 1995, pp. 811-817

MULTIPLE-SCLEROSIS - DIAGNOSTIC PROCEDURE S AND NEW THERAPEUTIC DEVELOPMENTS

Authors: KAPPOS L

Citation: L. Kappos, MULTIPLE-SCLEROSIS - DIAGNOSTIC PROCEDURE S AND NEW THERAPEUTIC DEVELOPMENTS, Schweizerische medizinische Wochenschrift, 125(25), 1995, pp. 1251-1263

CORRELATIONS BETWEEN CHANGES IN DISABILITY AND T-2-WEIGHTED BRAIN MRIACTIVITY IN MULTIPLE-SCLEROSIS - A FOLLOW-UP-STUDY

Authors: FILIPPI M PATY DW KAPPOS L BARKHOF F COMPSTON DAS THOMPSON AJ ZHAO GJ WILES CM MCDONALD WI MILLER DH

Citation: M. Filippi et al., CORRELATIONS BETWEEN CHANGES IN DISABILITY AND T-2-WEIGHTED BRAIN MRIACTIVITY IN MULTIPLE-SCLEROSIS - A FOLLOW-UP-STUDY, Neurology, 45(2), 1995, pp. 255-260

CEREBROSPINAL-FLUID OF MULTIPLE-SCLEROSIS PATIENTS - MOLECULAR AND FUNCTIONAL ANALYSES OF T-CELL RECEPTOR-GAMMA-DELTA REPERTOIRE IS SKEWED IN ANTIGEN-REACTIVE GAMMA-DELTA CLONES

Authors: NICK S PILERI P TONGIANI S UEMATSU Y KAPPOS L DELIBERO G

Citation: S. Nick et al., CEREBROSPINAL-FLUID OF MULTIPLE-SCLEROSIS PATIENTS - MOLECULAR AND FUNCTIONAL ANALYSES OF T-CELL RECEPTOR-GAMMA-DELTA REPERTOIRE IS SKEWED IN ANTIGEN-REACTIVE GAMMA-DELTA CLONES, European Journal of Immunology, 25(2), 1995, pp. 355-363

GANGLIOSIDES AND AUTOIMMUNE NEUROPATHIES - CLASSIFICATION AND CLINICAL ASPECTS OF AUTOIMMUNE NEUROPATHIES

Authors: STECK AJ KAPPOS L

Citation: Aj. Steck et L. Kappos, GANGLIOSIDES AND AUTOIMMUNE NEUROPATHIES - CLASSIFICATION AND CLINICAL ASPECTS OF AUTOIMMUNE NEUROPATHIES, Journal of Neurology, Neurosurgery and Psychiatry, 57, 1994, pp. 26-28

LACK OF ASSOCIATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES AND MIGRAINE

Authors: TSAKIRIS DA KAPPOS L REBER G MARBET GA LEFLOCHROHR J ROUX E DEMOERLOOSE P

Citation: Da. Tsakiris et al., LACK OF ASSOCIATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES AND MIGRAINE, Thrombosis and haemostasis, 69(5), 1993, pp. 415-417

DATABASE FOR SERIAL MAGNETIC-RESONANCE-IMAGING IN MULTIPLE-SCLEROSIS

Authors: BARKHOF F THOMPSON AJ KAPPOS L NAUTA JJP YOUSRI T BERRY I SCOTTI G APPEL B TOFTS PS MILLER DH

Citation: F. Barkhof et al., DATABASE FOR SERIAL MAGNETIC-RESONANCE-IMAGING IN MULTIPLE-SCLEROSIS, Neuroradiology, 35(5), 1993, pp. 362-366

Risultati: 1-24 |